Ellevest Inc’s CareDx CDNA Stock Holding History

Ellevest Inc’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14	Closed	–	–	1863
2022 Q3	$0	Sell	14 -3	-18%	-$64	﹤0.01%	1635
2022 Q2	$0	Buy	+17	New	+$471	﹤0.01%	1424
2021 Q4	–	Sell	-6	Closed	–	–	1445
2021 Q3	$0	Buy	+6	New	+$457	﹤0.01%	1421

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ellevest Inc's CDNA Position: Q4 2022 in Review

Ellevest Inc sold out of CareDx (CDNA) in Q4 2022, closing a stake of 14 shares.

Ellevest Inc first reported a position in CDNA in Q3 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

Ellevest Inc reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 14 CareDx shares in Q4 2022.
Ellevest Inc first reported a position in CareDx in Q3 2021 and held it in 3 quarters.
Ellevest Inc's CareDx position peaked at $0 in Q3 2022.
168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.